Synthon Biopharmaceuticals announces promising results with its antibody-drug conjuga
Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).
More... |
Re: Synthon Biopharmaceuticals announces promising results with its antibody-drug con
Thanks for posting . This looks very interesting especially low toxicity and efficacy against her 2 .
Ellie |
All times are GMT -7. The time now is 10:32 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021